Mammography screening in elderly women: Efficacy and cost-effectiveness

Critical Reviews in Oncology/Hematology

Volumn 46, Issue 3, 2003, Pages 235-239

  Zappa, Marco ^a   Visioli, Carmen Beatriz ^a   Ciatto, Stefano ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Aged; Breast cancer; Cost effectiveness analysis; Mammography; Mass screening

Indexed keywords

AGE; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL INFORMATICS; MEDICAL INFORMATION; POPULATION RESEARCH; PROGNOSIS; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; SCREENING TEST; SENESCENCE; SENSITIVITY ANALYSIS;

EID: 0038520931     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(03)00022-2     Document Type: Conference Paper

References (16)

1. Gotzsche P.C., Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 355:2000;129-134.
2. Shapiro S., Coleman E.A., Broeders M., et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int. J. Epidemiol. 27:1998;735-742.
3. Walter L.C., Covinsky K.E. Cancer screening in elderly patients. A framework for individualized decision making. J. Am. Med. Assoc. 285:2001;2750-2756.
4. http://www.guideline.gov (04/24/2002).
5. Nyström L., Andersson I., Bjurstam N., Frisell J., Nordenskjold, Rutqvist L.E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 359:2002;909-919.
6. Fletcher S.W., Black W., Harris R., Rimer B.K., Shapiro S. Report of the International Workshop on screening for breast cancer. J. Natl. Cancer Inst. 85:1993;1644-1656.
7. Kerlikowske K., Grady D., Barclay J., Sickles E.A., Eaton A., Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. J. Am. Med. Assoc. 270:1993;2444-2450.
8. Tabar L., Fagerberg G., Chen H.H., et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 75:1995;2507-2517.
9. Boer R., de Koning H.J., van der Maas P.J. A longer breast carcinoma screening interval for women age older than 65 years? Cancer. 86:1999;1506-1510.
10. Paci E., Ciatto S., Buiatti E., Cecchini S., Palli D., Rosselli del Turco M. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence District Programme. Int. J. Cancer. 46:1990;198-202.
11. Zappa M., Falini P., Bonardi R., Ambrogetti D., Giorgi D., Paci E., Ciatto S. Monitoring interval cancers in mammographic screening: the Florence District programme experience. The Breast. 11:2002;301-305.
12. Eddy D.M. Screening for breast cancer. Ann. Intern. Med. 111:1989;389-399.
13. Mandelblatt J.S., Wheat M.E., Moname M., Moshief R.D., Hollenberg J.P., Tang J. Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann. Intern. Med. 116:1992;722-730.
14. Kerlikowske K., Salzmann P., Phillips K.A., Cauley J.A., Cummings S.R. Continuing screening mammography in women aged 70 to 79 years. Impact on life expectancy and cost-effectiveness. J. Am. Med. Assoc. 282:1999;2156-2163.
15. Boer R., de Koning H.J., van Oortmarssen G.J., van der Maas P.J. In search of the best upper age limit for breast cancer screening. Eur. J. Cancer. 31A:1995;2040-2043.
16. Barratt A.L., Les Irwing M., Glasziou P.P., Salked G.P., Houssani N. Benefit, harms and costs of screening mammography in women 70 years over: a systematic review. Med. J. Aust. 176:2002;266-271.